DRUG TESTING – BLOOD

 

Delta-9-tetrahydrocannabinol: Metabolism and Disposition in Long-term Marihuana Smokers.     (abst – 1971)                                   http://www.ncbi.nlm.nih.gov/pubmed/5087483

 

Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9- carboxy-THC in blood and plasma.                                                                     (abst – 1984)  http://www.ncbi.nlm.nih.gov/pubmed/6094914

 

Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. (abst – 1986)                                         http://www.ncbi.nlm.nih.gov/pubmed/3018361

 

Serum cannabinoid levels 24 to 48 hours after cannabis smoking                      (abst – 2003)

http://www.ncbi.nlm.nih.gov/pubmed/14639811

 

Estimating the Time of Last Cannabis Use from Plasma {Delta}9-Tetrahydrocannabinol and 11-nor-9-Carboxy-{Delta}9-Tetrahydrocannabinol Concentrations                                                             (full – 2005)   http://www.clinchem.org/cgi/content/full/51/12/2289

 

Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.                                                         (abst – 2008)  http://www.ncbi.nlm.nih.gov/pubmed/18190663

 

Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.                                                    (abst – 2008)         http://www.ncbi.nlm.nih.gov/pubmed/18334100

 

Simultaneous analysis of THC and its metabolites in blood using liquid chromatography- tandem mass spectrometry.                                           (abst – 2008)        http://www.ncbi.nlm.nih.gov/pubmed/18922747

 

Do Delta(9)-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?   (full – 2009)                              http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784185/?tool=pmcentrez

 

A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood.     (abst – 2009)

 

 

 

 

 

 

 

 

http://www.unboundmedicine.com/medline/ebm/record/19630026/abstract/A_semi_automated_solid_phas  e_extraction_liquid_chromatography/tandem_mass_spectrometry_method_for_the_analysis_of_tetrahydro   cannabinol_and_metabolites_in_whole_blood_

 

Identification of Recent Cannabis Use:Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics Following Controlled Smoked Cannabis Administration.           (abst – 2009)                                        http://www.ncbi.nlm.nih.gov/pubmed/21836075

 

Quantitation of Total 11-Nor-9-Carboxy-Delta 9-Tetrahydrocannabinol in Urine and Blood Using Gas Chromatography-Mass Spectrometry (GC-MS).                                            (abst – 2010)  http://marijuana.researchtoday.net/archive/7/1/2746.htm

 

Concentrations of delta9-tetrahydrocannabinol and 11-nor-9- carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.         (abst – 2010)    http://www.ncbi.nlm.nih.gov/pubmed/20465865

 

Interpretation of blood analysis data found after passive exposure to cannabis (abst – 2010)

http://www.unboundmedicine.com/medline/ebm/record/20506708/abstract/%5BInterpretation_of_blood_a  nalysis_data_found_after_passive_exposure_to_cannabis%5D_

 

Testing for cannabis in the work-place: a review of the evidence.               (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20402984

 

Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral

{Delta}9-Tetrahydrocannabinol Administration.                (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21875944

 

Identification of Recent Cannabis Use:Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics Following Controlled Smoked Cannabis Administration.           (abst – 2011)                                       http://www.ncbi.nlm.nih.gov/pubmed/21836075

 

Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral

{Delta}9-Tetrahydrocannabinol Administration.               (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21875944

 

Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users. (abst – 2011)                                      http://www.ncbi.nlm.nih.gov/pubmed/21116612

 

Variability of cannabinoid findings in blood             (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21850885

 

Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration.                                                                              (abst – 2011)   http://www.unboundmedicine.com/medline/ebm/record/21078841/abstract/Plasma_cannabinoid_pharmaco kinetics_following_controlled_oral_delta9_tetrahydrocannabinol_and_oromucosal_cannabis_extract_admi  nistration_

 

Latest blood test detects 12 popular synthetic cannabinoids in “fake pot”.           (news – 2011)

 

 

 

 

 

 

 

 

http://www.thefreelibrary.com/Latest+blood+test+detects+12+popular+synthetic+cannabinoids+in+%22fa   ke…-a0261876557

 

Colorado’s 5ng/ml per se DUID bill dies again as new research backs higher thresholds for regular users (news – 2011)

http://stash.norml.org/colorados-5ngml-per-se-duid-bill-dies-again-as-new-research-backs-higher-  thresholds-for-regular-users

 

Detection and disposition of JWH-018 and JWH-073 in mice after exposure to “Magic Gold” smoke.      (abst – 2012)                            http://www.ncbi.nlm.nih.gov/pubmed/22405481

 

Predictive model accuracy in estimating last Δ(9)-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.          (abst – 2012)  http://www.sciencedirect.com/science/article/pii/S0376871612000798

 

Detection and quantification of new designer drugs in human blood: part 1 – synthetic cannabinoids.       (abst – 2012)                           http://www.ncbi.nlm.nih.gov/pubmed/22593567

 

Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction                                                        (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1002/jms.3020/abstract

 

Does a positive finding of tetrahydrocannabinol in the blood result from ingestion of Indian frankincense (Boswellia serrata)?                                                  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22834359

 

Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to ‘buzz’ smoke by HPLC/MS/MS

(abst – 2012)               http://onlinelibrary.wiley.com/doi/10.1002/bmc.2710/abstract

 

Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS.                                             (abst – 2012)          http://www.ncbi.nlm.nih.gov/pubmed/22847477

 

Distribution of free and conjugated cannabinoids in human bile samples.              (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22980143

 

Dried Blood Spots: Liquid chromatography-mass spectrometry analysis of Δ(9)- tetrahydrocannabinol and its main metabolites.                                                                      (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23228918

 

Simultaneous and sensitive LC–MS/MS determination of tetrahydrocannabinol and metabolites in human plasma                                                                 (abst – 2013)  http://link.springer.com/article/10.1007/s00216-012-6501-x

 

Study: Imposition Of Per Se Limits For Drugs Don’t Reduce Traffic Deaths (news – 2013)

http://norml.org/news/2013/01/17/study-imposition-of-per-se-limits-for-drugs-don-t-reduce-traffic-deaths

Share a link for